SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021
Virol Sin
.
2021 Oct;36(5):1236-1240.
doi: 10.1007/s12250-021-00446-z.
Epub 2021 Sep 30.
Authors
Zahra Heydarifard
1
,
Sevrin Zadheidar
1
,
Jila Yavarian
1
,
Shirin Kalantari
1
,
Ahmad Nejati
1
,
Talat Mokhtari-Azad
1
,
Nazanin Zahra Shafiei-Jandaghi
2
Affiliations
1
Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, 1417613151, Iran.
2
Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, 1417613151, Iran. nz-shafiei@tums.ac.ir.
PMID:
34591252
PMCID:
PMC8481754
DOI:
10.1007/s12250-021-00446-z
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Viral
COVID-19*
Humans
Iran / epidemiology
Laboratories
SARS-CoV-2*
Seroepidemiologic Studies
Substances
Antibodies, Viral